The company is recalling 5 lots of Ceftriaxone for Injection, USP, 250mg; 10 lots of Ceftriaxone for Injection, USP, 500mg; 24 lots of Ceftriaxone for Injection, USP, 1g; and 3 lots of Ceftriaxone for ...
September 11, 2007 — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated with concomitant use of ...
(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release, ADPH said it is ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Amid growing ...
Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g ...
Please provide your email address to receive an email when new articles are posted on . Fewer early ventilator-associated pneumonia cases occurred among patients with brain injury receiving ...
The FDA has notified healthcare professionals of an update to a previous alert from September 2007 addressing the interaction of ceftriaxone with calcium-containing products. At the FDA’s request, ...
Attenuation of Ethanol Withdrawal by Ceftriaxone-Induced Upregulation of Glutamate Transporter EAAT2
Alcohol withdrawal syndrome (AWS) is a potentially fatal outcome of severe alcohol dependence that presents a significant challenge to treatment. Although AWS is thought to be driven by a ...
July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback